Skip to main content

Table 2 Geographic distribution of prevalence studies of cardiovascular disease in type 2 diabetes mellitus

From: Prevalence of cardiovascular disease in type 2 diabetes: a systematic literature review of scientific evidence from across the world in 2007–2017

Region Populationa (millions) Studies N Stroke (%) MI Angina Heart failure Atherosclerosis CAD CVD (%)
Africa 441 1 132 5.0 NR NR NR NR 23.6% 28.6
Europe 660 29b 4,327,503 7.2 10.0% 14.6% 19.0% 33.0% 15.4% 30.0
Middle East and North Africa 387 4 3959 7.1 11.4% NR NR NR 27.4% 26.9
North America and Caribbean 344 8 170,963 10.9 13.6% 17.2% 29.5% NR 20.1% 46.0
South and Central America 315 2 537 5.5 NR NR 4.2% NR 22.6% 27.5
Southeast Asia 926 3b 1656 3.1 NR NR NR NR 29.4% 42.5
Western Pacific (includes China) 1600 12b 44,062 11.4 NR NR 4.3% 26.0% 23.6% 33.6
Multiple countries NR 1 669 1.9 3.9% 9.9% 0.7% NR NR 16.4
Totalc 4673 60 4,549,481 7.6 10.0% 14.6% 14.9% 29.1% 21.2% 32.2
  1. CAD coronary artery disease, CVD cardiovascular disease (includes all complications), MI myocardial infarction, NR not reported
  2. aAdults aged 20–79. Source: IDF Atlas 2015 [1]
  3. bA study reports two separate analyses within the same paper; thus, there are 60 studies in 57 articles
  4. cPrevalence rates weighted by inverse variance